Rupa & Company Limited has informed the Exchange about Schedule of meet
Chembond Chemicals Ltd with respect to announcement dated 12-Jan-2022, regarding Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify following:? 1. Brief details of change in shareholding pattern (if any) of listed entity. 2. Name of the entity (ies) forming part of the amalgamation/merger, details in brief such as, size, turnover etc.; 3. Whether the transaction would fall within related party transactions? If yes, whether the same is done at arms length; 4. Area of business of the entity (ies); 5. Rationale for amalgamation/ merger; 6. In case of cash consideration amount or otherwise share entitlement/exchange ratio; The response of the Company is awaited.
Cinevista Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 17, 2022, titled Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single‐Dose Pre‐Filled Syringe.
Blue Dart Express Limited has informed the Exchange about Copy of Newspaper Publication Enclosed please find herewith copy of the Notice of the Board Meeting published in the following newspapers for your information and records. 1.)The Economic Times, Mumbai Edition on January 17, 2022 2.) Maharashtra Times, Mumbai Edition on January 17, 2022
The South Indian Bank Limited has informed the Exchange about Loss of Share Certificates
Goodluck India Limited has informed the Exchange about Schedule of meet
Kothari Products Limited has informed the Exchange regarding DIVESTMENT OF SHARES OF STEP DOWN SUBSIDIARY M/S PINEHILLS SINGAPORE PTE LTD. OF THE COMPANY.
Mahindra Lifespace Developers Limited has informed the Exchange about Loss of Share Certificates
NXTDIGITAL LIMITED has informed the Exchange regarding a press release dated January 14, 2022, titled Press Release under Regulation 30 .
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
